Sysmex (SSMXY) Expected to Announce Earnings on Wednesday

Sysmex (OTCMKTS:SSMXY) is expected to be announcing its results after the market closes on Wednesday, November 4th. Analysts expect Sysmex to post earnings of $0.0944 per share and revenue of $854.07 million for the quarter. Sysmex has set its FY 2026 guidance at 0.382-0.382 EPS.

Sysmex (OTCMKTS:SSMXY) last posted its quarterly earnings data on Friday, August 7th. The company reported $0.09 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.07 by $0.02. The business had revenue of $825.85 million during the quarter, compared to the consensus estimate of $741.67 million. On average, analysts expect Sysmex to post $0.41 EPS for the current fiscal year and $0.47 EPS for the next fiscal year.

Sysmex Stock Performance

Shares of OTCMKTS:SSMXY opened at $12.28 on Wednesday. The company’s 50 day moving average price is $11.94 and its two-hundred day moving average price is $9.92. Sysmex has a 12-month low of $8.01 and a 12-month high of $13.01.

Analyst Upgrades and Downgrades

Separately, Zacks Research upgraded Sysmex from a “strong sell” rating to a “hold” rating in a research note on Tuesday, August 18th. Two research analysts have rated the stock with a Hold rating. Based on data from MarketBeat, the company presently has a consensus rating of “Hold”.

About Sysmex

Sysmex Corporation is a Japan-based healthcare technology company that develops, manufactures and distributes clinical laboratory instruments, reagents and related information systems. Its products are used by hospitals, diagnostic laboratories and other healthcare providers to support the analysis of blood, urine and other biological samples.

The company is best known for its hematology analyzers, which help laboratories evaluate blood cells and identify conditions such as anemia and leukemia.